Affluent Medical SA (FR:AFME) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Affluent Medical SA, a French medical technology company, is set to participate in several key scientific conferences in Q4 2024, aiming to showcase their innovative implantable medical devices for heart diseases and urinary incontinence. The company has reported progress in its medical devices, including a partnership with Edward Lifesciences and promising clinical trial results. With the goal of commercial launch by 2025/early 2026, Affluent Medical is advancing towards pivotal studies and approvals in their mission to improve patient care.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.